½ÃÀ庸°í¼­
»óǰÄÚµå
1771509

¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¾·ùº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

U.S. Radiofrequency Electrosurgery Generators Market Size, Share & Trends Analysis Report By Type (Monopolar, Bipolar, Hybrid), By Application (General Surgery, Gynecological Surgery, ENT Surgery) By End Use, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÃÀå ±Ô¸ð¿Í µ¿Çâ:

¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 3¾ï 4,662¸¸ ´Þ·¯·Î 2025³âºÎÅÍ 2030³â±îÁö 2.63%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼ö¼ú °Ç¼öÀÇ Áõ°¡, ÃÖ¼Ò Ä§½À ±â¼úÀÇ ºÎ»ó, Àü±â ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀº ¿¹Ãø ±â°£ µ¿¾È ¹Ì±¹ °íÁÖÆÄ Àü±â ¼ö¼ú ¹ßÀü±â »ê¾÷ÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Paras Health°¡ 2025³â 1¿ù ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, Àü ¼¼°èÀûÀ¸·Î ¸Å³â 1,300¸¸ °Ç ÀÌ»óÀÇ º¹°­°æ ¼ö¼úÀÌ ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸¹Àº ÃÖ¼Ò Ä§½À ¼ö¼ú°ú °íÁÖÆÄ(RF) Àü±â ¼ö¼ú¿ë ¹ßÀü±âÀÇ °¡¿ë¼ºÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ¿Í ÀÇ·áÁøÀº ȸº¹ ½Ã°£ ´ÜÃà, ÅëÁõ °¨¼Ò, ÈäÅÍ ÃÖ¼ÒÈ­, ÀÔ¿ø ±â°£ ´ÜÃà µî ´Ù¾çÇÑ ÀÌÁ¡ÀÌ ÀÖ´Â ÃÖ¼Òħ½À ¼ö¼úÀ» Á¡Á¡ ´õ ¼±È£Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡À¸·Î ÀÎÇØ Àü ¼¼°è°¡ ÃÖ¼Òħ½À ¼ö¼ú·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. °íÁÖÆÄ(RF) Àü±â¼ö¼ú¿ë ¹ßÀü±â´Â Á¤È®ÇÑ Àý´Ü°ú ÀÀ°í¸¦ °¡´ÉÇϰÔÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ½Ã¼ú¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÷´Ü ¼ö¼ú ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÇöÀç ¸¹Àº ¼ö¼úÀÌ ÃÖ¼Òħ½À ¼ö¼ú·Î ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(ASPS)ÀÇ 2023³â º¸°í¼­¿¡ µû¸£¸é, ÃÖ¼Òħ½À ¼ö¼úÀº Àü³â ´ëºñ 7% Áõ°¡ÇÏ¿© 2,500¸¸ °Ç ÀÌ»óÀÇ ¼ö¼úÀÌ ÀÌ·ç¾îÁ³´Ù°í ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±Þ°ÝÇÑ Áõ°¡´Â Àç°Ç ¹× ¹Ì¿ë ¼ö¼ú¿¡¼­ º¸´Ù ÃÖ¼Òħ½ÀÀûÀÎ ¼±ÅÃÀÌ ¼±È£µÇ°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ¼ºÇü ¹× ¹Ì¿ë ¼ö¼ú¿¡¼­ RF Àü±â¼ö¼ú¿ë ¹ßÀü±âÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀº ÀÌ·¯ÇÑ ¼ºÀå ±Ëµµ¸¦ À¯ÁöÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È RF Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀåÀÇ Ãß°¡ È®ÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ï, ½ÉÇ÷°üÁúȯ, ½Å°æ Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ Áõ°¡´Â °íÁÖÆÄ(RF) Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº Á¾Á¾ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇϸç, Á¤È®¼º°ú Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, º¸½ºÅÏ »çÀ̾ðƼÇÈ(Boston Scientific)ÀÇ RF 3000 ¹ßÀü±â´Â ¿¬Á¶Á÷ÀÇ ¿­ ÀÀ°í ¹× ±«»ç¸¦ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ Á¦Ç°ÀÔ´Ï´Ù. ÀÌ´Â ÀϹÝÀûÀ¸·Î ÀýÁ¦ ºÒ°¡´ÉÇÑ °£ º´º¯ÀÇ ºÎºÐÀû ¶Ç´Â ¿ÏÀüÇÑ ÀýÁ¦¼ú¿¡ »ç¿ëµÇ¾î ÃÖ¼Òħ½ÀÀû Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. µû¶ó¼­ ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °íÁÖÆÄ Àü±â¼ö¼ú ¹ßÀü±â ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¿¬°ü Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀå °úÁ¦ ºÐ¼®
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ºÐ¼® Åø
    • ¾÷°è ºÐ¼® : Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : Á¾·ùº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : º¯µ¿ ºÐ¼®, Á¾·ùº°
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : Á¾·ùº°(2018-2030³â)
  • ¸ð³ëÆú¶ó
  • ¹ÙÀÌÆú¶ó
  • ÇÏÀ̺긮µå

Á¦5Àå ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : º¯µ¿ ºÐ¼®, ¿ëµµº°
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : ¿ëµµº°(2018-2030³â)
  • ÀϹݿܰú
  • ºÎÀΰú ¼ö¼ú
  • ½ÉÇ÷°ü¿Ü°ú
  • Á¤Çü¿Ü°ú
  • ½Å°æ¿Ü°ú
  • ºñ´¢±â°ú ¼ö¼ú
  • À̺ñÀÎÈİú ¼ö¼ú
  • ±âŸ

Á¦6Àå ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : º¯µ¿ ºÐ¼®, ÃÖÁ¾ ¿ëµµº°
  • ¹Ì±¹ÀÇ °íÁÖÆÄ Àü±â¼ö¼ú¿ë ¹ßÀü±â ½ÃÀå : ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м® : ÃÖÁ¾ ¿ëµµº°(2018-2030³â)
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ä¡°ú¡¤±¸°­¿Ü°ú Ŭ¸®´Ð
  • Á¤Çü¿Ü°ú¡¤½ºÆ÷Ã÷ ÀÇÇРŬ¸®´Ð
  • ÅëÁõ °ü¸® Ŭ¸®´Ð
  • ³»½Ã°æ ¼¾ÅÍ
  • È­»ó¡¤¿Ü»ó ¼¾ÅÍ
  • ¿¬±¸¡¤ÀÓ»ó½ÃÇè ¼¾ÅÍ
  • ±âŸ

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÀÔ ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • ETHICON(Johnson & Johnson)
    • Abbott
    • Olympus America
    • Sutter Medical Technologies USA
    • elliquence
    • Medtronic.
    • Boston Scientific Corporation or its affiliates.
    • Aspen Surgical Products, Inc
    • Erbe USA, Incorporated.
    • Intuitive Surgical
ksm 25.07.24

Market Size & Trends:

The U.S. radiofrequency electrosurgery generators market size was valued at USD 346.62 million in 2024 and is expected to grow at a CAGR of 2.63% from 2025 to 2030. The rising number of surgical procedures, the rise of minimally invasive techniques, and advancements in electrosurgical technology are anticipated to drive the U.S. radiofrequency electrosurgery generators industry over the forecast period. According to the data published by Paras Health in January 2025, over 13 million laparoscopic procedures are performed globally each year. Such a large number of minimally invasive procedures and the availability of radiofrequency (RF) electrosurgery generators are anticipated to propel the market growth in the coming years.

Patients and healthcare providers increasingly prefer minimally invasive procedures for their numerous benefits, including faster recovery times, reduced pain, minimal scarring, and shorter hospital stays. These advantages are driving a global shift toward less invasive surgical techniques. Radiofrequency (RF) electrosurgery generators play a critical role in these procedures by enabling precise cutting and coagulation, thereby supporting the growing demand and market expansion for advanced surgical technologies.

Furthermore, many surgeries are now being performed using minimally invasive methods. According to the American Society of Plastic Surgeons (ASPS) 2023 report, minimally invasive procedures increased by 7% year-over-year, with over 25 million procedures performed. This surge highlights the growing preference for less invasive options in reconstructive and aesthetic surgery. The widespread use of RF electrosurgery generators in plastic and cosmetic procedures is expected to play a crucial role in sustaining this growth trajectory, driving further expansion of the RF electrosurgery generators market over the forecast period.

The increasing burden of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, is a significant driver of growth in the radiofrequency (RF) electrosurgery generator market. These conditions often require surgical intervention, where precision and minimal tissue damage are critical. For instance, the RF 3000 Generator from Boston Scientific is designed explicitly for thermal coagulation and necrosis of soft tissues. It is commonly used for partial or complete ablation of nonresectable liver lesions, offering a minimally invasive treatment alternative. Thus, with the growing prevalence of chronic disorders, demand for radiofrequency electrosurgery generators is anticipated to increase significantly over the forecast period.

U.S. Radiofrequency Electrosurgery Generators Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. radiofrequency electrosurgery generators market report based on type, application, and end use.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Monopolar
  • Bipolar
  • Hybrid
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • General Surgery
  • Gynecological Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Urological Surgery
  • ENT Surgery
  • Other
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Specialty Clinics
    • Dermatology Clinics
    • Urology Clinics
    • Gynecology Clinics
    • ENT (Ear, Nose, and Throat) Clinics
    • Plastic Surgery Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Dentistry and Oral Surgery Clinics
    • Oral Surgery Practices
    • Periodontics Clinics
  • Orthopedic and Sports Medicine Clinics
  • Pain Management Clinics
  • Endoscopy Centers
  • Burn and Trauma Centers
  • Research and Clinical Trial Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Radiofrequency Electrosurgery Generators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of chronic disorders
      • 3.2.1.2. Rising number of surgical procedures
      • 3.2.1.3. Technological advancements in electrosurgery generators
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product recalls
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Expansion in emerging economies
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Shortage of skilled professionals
  • 3.3. U.S. Radiofrequency Electrosurgery Generators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Radiofrequency Electrosurgery Generators Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Radiofrequency Electrosurgery Generators Market Type Movement Analysis
  • 4.3. U.S. Radiofrequency Electrosurgery Generators Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Monopolar
    • 4.4.1. Monopolar Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Bipolar
    • 4.5.1. Bipolar Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Hybrid
    • 4.6.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Radiofrequency Electrosurgery Generators Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Radiofrequency Electrosurgery Generators Market Application Movement Analysis
  • 5.3. U.S. Radiofrequency Electrosurgery Generators Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. General Surgery
    • 5.4.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gynecological Surgery
    • 5.5.1. Gynecological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cardiovascular Surgery
    • 5.6.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Orthopedic Surgery
    • 5.7.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Neurological Surgery
    • 5.8.1. Neurological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Urological Surgery
    • 5.9.1. Urological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. ENT Surgery
    • 5.10.1. ENT Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Radiofrequency Electrosurgery Generators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Radiofrequency Electrosurgery Generators Market End Use Movement Analysis
  • 6.3. U.S. Radiofrequency Electrosurgery Generators Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.1. Dermatology Clinics
        • 6.5.1.1.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.2. Urology Clinics
        • 6.5.1.2.1. Urology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.3. Gynecology Clinics
        • 6.5.1.3.1. Gynecology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.4. ENT (Ear, Nose, and Throat) Clinics
        • 6.5.1.4.1. ENT (Ear, Nose, and Throat) Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.1.5. Plastic Surgery Clinics
        • 6.5.1.5.1. Plastic Surgery Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Dentistry and Oral Surgery Clinics
    • 6.7.1. Dentistry and Oral Surgery Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.1. Oral Surgery Practices
        • 6.7.1.1.1. Oral Surgery Practices Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.7.1.2. Periodontics Clinics
        • 6.7.1.2.1. Periodontics Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Orthopedic and Sports Medicine Clinics
    • 6.8.1. Orthopedic and Sports Medicine Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Pain Management Clinics
    • 6.9.1. Pain Management Clinics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Endoscopy Centers
    • 6.10.1. Endoscopy Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Burn and Trauma Centers
    • 6.11.1. Burn and Trauma Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Research and Clinical Trial Centers
    • 6.12.1. Research and Clinical Trial Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Others
    • 6.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. ETHICON (Johnson & Johnson)
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Product Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Abbott
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Product Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Olympus America
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Sutter Medical Technologies USA
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. elliquence
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. Medtronic.
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Boston Scientific Corporation or its affiliates.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. Aspen Surgical Products, Inc
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. Erbe USA, Incorporated.
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Product Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Intuitive Surgical
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Product Benchmarking
      • 7.2.10.4. Strategic Initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦